The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders(488 views) Caraci F, Busceti C, Biagioni F, Aronica E, Mastroiacovo F, Cappuccio I, Battaglia G, Bruno V, Caricasole A, Copani A, Nicoletti
Neurochemical Research (ISSN: 0364-3190, 1573-6903), 2008 Dec; 33(12): 2401-2406.
Department of Pharmaceutical Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy
I.N.M. Neuromed, Località Camerelle, 86077 Pozzilli, Italy
Department of Neuropathology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
Department of Human Physiology and Pharmacology, University of Rome La Sapienza, 00185 Rome, Italy
Siena Biotech, Siena, Italy
I.B.B., CNR-Catania, 95125 Catania, Italy
I. N. M. Neuromed, Localit Camerelle, 86077 Pozzilli, Italy
I. B. B., CNR-Catania, 95125 Catania, Italy
References: Not available.
The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders